Skip to main content
. 2020 Dec 15;12(1):1849998. doi: 10.1080/19490976.2020.1849998

Figure 5.

Figure 5.

Subdoligranulum variabile supplementation does not impact on short-chain fatty acids or gut barrier

Effect of Subdoligranulum variabile administration on (A) short-chain fatty acids (nmol/g of dry cecal content) and (B) relative mRNA expression of key markers of gut barrier integrity. (ZO-1: Zonula occludens-1). Data are represented as means ± SEM. Data were analyzed using one-way ANOVA followed by a Tukey post hoc test.